Associated Papers
The pharmacogenetics of the new-generation antipsychotics - A scoping review focused on patients with severe psychiatric disorders.
Vasiliu O
Frontiers in Psychiatry, 2023
5-HT2A SNPs Alter the Pharmacological Signaling of Potentially Therapeutic Psychedelics.
Schmitz GP et al.
Acs Chemical Neuroscience, 2022
A review of genetic alterations in the serotonin pathway and their correlation with psychotic diseases and response to atypical antipsychotics.
Baou M et al.
Schizophrenia Research, 2016
Computational exploration of polymorphisms in 5-hydoxytryptamine 5-HT₁A and 5-HT₂A receptors associated with psychiatric disease.
Dass JF et al.
Gene, 2012
Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs.
Davies MA et al.
Biological Research for Nursing, 2011
An improved in silico selection of phenotype affecting polymorphisms in SLC6A4, HTR1A and HTR2A genes.
Piva F et al.
Human Psychopharmacology, 2010
Association analysis between the C516T polymorphism in the 5-HT2A receptor gene and schizophrenia.
Bertola V et al.
Arquivos De Neuro-psiquiatria, 2007
Functional polymorphisms in dopamine and serotonin pathway genes.
D'Souza UM et al.
Human Mutation, 2006
HTR2A: association and expression studies in neuropsychiatric genetics.
Norton N et al.
Annals of Medicine, 2005
Human genetic variations in the 5HT2A receptor: a single nucleotide polymorphism identified with altered response to clozapine.
Harvey L et al.
Pharmacogenetics, 2003
Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies.
Davies MA et al.
The Pharmacogenomics Journal, 0
Impact of the -1438G>a polymorphism in the serotonin 2A receptor gene on anthropometric profile and obesity risk: a case-control study in a Spanish Mediterranean population.
Sorlí JV et al.
Appetite, 0
Select a paper to view details